Human alveolar macrophage gene responses to Mycobacterium tuberculosis strains H37Ra and H37Rv.
H37Rv and H37Ra have been widely used as models of virulent and avirulent strains, respectively, of Mycobacterium tuberculosis. Since the sequencing of H37Rv, microarrays have been used to investigate gene expression of M. tuberculosis strains under various conditions, and to compare gene expression of specific isolates of the organism. Because differences in the virulence of these organisms could also be manifest via their differential induction of host genes, we used Affymetrix Human Genome Arrays U133A and U133B to evaluate human alveolar macrophage (AM) responses to infection with H37Rv and H37Ra. H37Rv altered expression of far more genes than did H37Ra. Moreover, the genes induced by H37Rv to a greater extent than by H37Ra were predominantly associated with the development of effective immunity. H37Rv markedly increased expression of IL-23 p19, whereas neither organism significantly induced IL-12 p35 expression. Quantitative PCR confirmed that H37Rv induced significantly more AM p19 expression than did H37Ra. After low-level infection of both AM and peripheral blood monocytes (MN) with H37Rv, neither cell type produced IL-12 (by ELISA). In contrast, AM displayed significant IL-23 production in response to H37Rv, whereas MN did not. Our findings thus suggest an important role for IL-23 in human host responses to pulmonary infection with M. tuberculosis, and are consistent with epidemiologic and genetic studies that imply that H37Rv may not have unusual capacity to cause human disease.
Silver
Richard F
RF
Division of Pulmonary, Critical Care, and Sleep Medicine, Biomedical Research Building, Rm. 1030, Case Western Reserve University School of Medicine, 10900 Euclid Avenue, Cleveland, OH 44106-4984, USA. rfs4@po.cwru.edu
Walrath
Jessica
J
Lee
Hung
H
Jacobson
Bruce A
BA
Horton
Heidi
H
Bowman
Michael R
MR
Nocka
Karl
K
Sypek
Joseph P
JP
D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology / Q000382:microbiology; D015536:Down-Regulation / Q000235:genetics; D005786:Gene Expression Regulation; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000096:biosynthesis; D006801:Humans; D053759:Interleukin-23 / Q000096:biosynthesis; D042541:Intracellular Space / Q000382:microbiology; D016676:Macrophages, Alveolar / Q000378:metabolism* / Q000382:microbiology*; D009000:Monocytes / Q000378:metabolism / Q000382:microbiology; D009169:Mycobacterium tuberculosis / Q000145:classification / Q000502:physiology*; D020411:Oligonucleotide Array Sequence Analysis; D016133:Polymerase Chain Reaction; D014376:Tuberculosis / Q000235:genetics / Q000382:microbiology; D015854:Up-Regulation / Q000235:genetics
D053759:Interleukin-23; D016178:Granulocyte-Macrophage Colony-Stimulating Factor
J Immunol. 1998 Mar 1;160(5):2408-17
9498784
Mol Microbiol. 2002 Feb;43(3):717-31
11929527
Genome Biol. 2001;2(12):RESEARCH0055
11790258
J Clin Microbiol. 2000 Sep;38(9):3200-4
10970357
Infect Immun. 1983 Feb;39(2):793-9
6403460
Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9869-74
9275218
J Infect Dis. 2005 Feb 1;191(3):453-60
15633105
J Exp Med. 1953 Feb 1;97(2):189-206
13022873
Science. 1998 May 29;280(5368):1432-5
9603732
J Immunol. 2005 Jul 15;175(2):788-95
16002675
J Exp Med. 1993 Jun 1;177(6):1723-33
8496688
Am J Respir Cell Mol Biol. 2005 Jul;33(1):48-55
15778493
Thorax. 1993 Jan;48(1):26-32
8434349
Infect Immun. 1998 Mar;66(3):1190-9
9488413
Infect Immun. 1998 Feb;66(2):794-9
9453643
Infect Immun. 1996 Jul;64(7):2523-31
8698475
J Exp Med. 1997 Jul 7;186(1):39-45
9206995
Nature. 2004 Sep 2;431(7004):84-7
15343336
Immunity. 2000 Nov;13(5):715-25
11114383
Infect Immun. 1993 Jul;61(7):2763-73
8514378
Am J Respir Cell Mol Biol. 2003 Nov;29(5):545-51
12748057
Am Rev Tuberc. 1946 Jul;54:62-6
20995860
Emerg Infect Dis. 2002 Aug;8(8):843-9
12141971
J Biol Chem. 2003 Jan 17;278(3):1910-4
12417590
N Engl J Med. 1998 Mar 5;338(10):633-9
9486991
Science. 1998 May 29;280(5368):1435-8
9603733
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4560-5
15070757
Infect Immun. 2002 Nov;70(11):6489-93
12379735
Infect Immun. 2004 Sep;72(9):5511-4
15322056
J Bacteriol. 2002 Jul;184(14):4025-32
12081975
Nature. 1998 Jun 11;393(6685):537-44
9634230
Microbiology (Reading). 2005 Jan;151(Pt 1):5-14
15632420
J Infect Dis. 1999 May;179(5):1213-7
10191225
J Immunol. 2000 Feb 15;164(4):2016-20
10657653
J Immunol. 2002 Feb 1;168(3):1322-7
11801672
J Leukoc Biol. 2005 Jun;77(6):914-22
15767289
Infect Immun. 1999 Nov;67(11):5768-74
10531227
J Clin Microbiol. 2004 Mar;42(3):1064-8
15004054
Clin Infect Dis. 1999 Jul;29(1):85-92; discussion 93-5
10433569
Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1503-8
11805289
Am Rev Respir Dis. 1969 Nov;100(5):631-9
4987090
Nat Immunol. 2007 Apr;8(4):369-77
17351619
Am J Respir Cell Mol Biol. 1998 Sep;19(3):513-21
9730880